ProBio provides end‑to‑end CGT support, covering CMC for plasmids, viral vectors, mRNA vaccines, and nucleic acid drugs, from IND filing through clinical and commercial manufacturing. Our integrated CMC services span cell banking, process development, characterization and validation, analytical development, and stability studies.
Who We Are?
ProBio, a subsidiary of GenScript, is a global CDMO offering end-to-end services from discovery to GMP for plasmids,
antibodies, and cell & gene therapies. We bring together multidisciplinary expertise to accelerate development and
manufacturing through customized, and comprehensive services.
What We Do?
We also offer innovative biologics discovery and development capabilities, including antibody discovery, engineering, and in vitro/in vivo pharmacology. ProBio delivers a full DNA‑to‑GMP platform with stable cell line development, host cell licensing, process and analytical development, and clinical to commercial manufacturing.
How We Deliver
ProBio has established companies in the United States, the Netherlands, South Korea, and China (Hong Kong, Shanghai, and Nanjing) and other regions to serve global customers, and has helped customers in the United States, Europe, Asia Pacific and other regions obtain more than 150 IND approvals since October 2017.
We have established GMP capacity meeting the regulatory requirements of the US Food and Drug Administration (FDA), European Medicines Agency (EMA) and National Medical Products Administration (NMPA).
We have established GMP capacity meeting the regulatory requirements of the US Food and Drug Administration (FDA), European Medicines Agency (EMA) and National Medical Products Administration (NMPA).
Global Footprint & Locations
ProBio operates a growing global network of development and manufacturing facilities to support U.S. and international programs.
United States
Hopewell, New Jersey — A U.S.-based Cell & Gene Therapy Center of Excellence specializing in plasmid DNA and viral vector development and GMP manufacturing. The Hopewell site is designed to meet FDA regulatory expectations and support close collaboration with U.S. clients.
China (CN)
Multiple sites supporting discovery, development, and GMP manufacturing across modalities. Our global footprint enables proximity to customers, alignment with regional regulatory requirements, and reliable supply across key markets.
Proven Quality & Credibility
Our Mission & Vision
Our Mission
Through our commitment to quality, collaboration, and innovation, ProBio delivers customized solutions to transform scientific discoveries into market-ready therapies, to make a lasting impact on patients’ health and well-being.
Our Vision
To be a leading global CDMO, renowned for cutting-edge technology to enable our customers to deliver life-changing therapies worldwide.
Frequently Asked Questions
